HIF1A and neoplasm: Oral administration of tetrahydrocurcumin significantly decreased the levels of HIF-1α, VEGF, and VEGF receptor-2 in the CaSki tumor tissue; this supports the inhibitory effect of tetrahydrocurcumin on tumor angiogenesis [74].